The competent European regulatory authority will start investigating next week whether clinical trials of the Russian vaccine against COVID-19 Sputnik V followed the global clinical and scientific standards, the Financial Times writes today, as reported by APE.
His research European Medicines Agency (EMA) as sources close to the regulatory approval process told the FT that the Sputnik V tests were not conducted in accordance with ethical rules.
“There was no pressure (on the participants) and Sputnik V responds to all clinical practices,” Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF), told the newspaper.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
